149 related articles for article (PubMed ID: 7923113)
1. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma.
Albrecht S; von Schweinitz D; Waha A; Kraus JA; von Deimling A; Pietsch T
Cancer Res; 1994 Oct; 54(19):5041-4. PubMed ID: 7923113
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity on chromosome 1 in human hepatoblastoma.
Kraus JA; Albrecht S; Wiestler OD; von Schweinitz D; Pietsch T
Int J Cancer; 1996 Aug; 67(4):467-71. PubMed ID: 8759602
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
Davies SM
Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
[TBL] [Abstract][Full Text] [Related]
4. Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma.
Montagna M; Menin C; Chieco-Bianchi L; D'Andrea E
J Cancer Res Clin Oncol; 1994; 120(12):732-6. PubMed ID: 7798299
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity on chromosome 11p15.5 and relapse in hepatoblastomas.
Chitragar S; Iyer VK; Agarwala S; Gupta SD; Sharma A; Wari MN
Eur J Pediatr Surg; 2011 Jan; 21(1):50-3. PubMed ID: 21053162
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma.
Pietsch T; Fonatsch C; Albrecht S; Maschek H; Wolf HK; von Schweinitz D
Lab Invest; 1996 Apr; 74(4):809-18. PubMed ID: 8606490
[TBL] [Abstract][Full Text] [Related]
7. p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.
Hartmann W; Waha A; Koch A; Goodyer CG; Albrecht S; von Schweinitz D; Pietsch T
Am J Pathol; 2000 Oct; 157(4):1393-403. PubMed ID: 11021841
[TBL] [Abstract][Full Text] [Related]
8. Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver.
Byrne JA; Simms LA; Little MH; Algar EM; Smith PJ
Genes Chromosomes Cancer; 1993 Oct; 8(2):104-11. PubMed ID: 7504513
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive allelotyping of hepatoblastoma.
Terada Y; Matsumoto S; Bando K; Tajiri T
Hepatogastroenterology; 2009; 56(89):199-204. PubMed ID: 19453057
[TBL] [Abstract][Full Text] [Related]
10. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
[TBL] [Abstract][Full Text] [Related]
11. Allelic loss but absence of mutations in the polyspecific transporter gene BWR1A on 11p15.5 in hepatoblastoma.
Albrecht S; Hartmann W; Houshdaran F; Koch A; Gärtner B; Prawitt D; Zabel BU; Russo P; Von Schweinitz D; Pietsch T
Int J Cancer; 2004 Sep; 111(4):627-32. PubMed ID: 15239143
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors.
Schofield DE; Beckwith JB; Sklar J
Genes Chromosomes Cancer; 1996 Jan; 15(1):10-7. PubMed ID: 8824720
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity at 11p15 in malignant glioma.
Sonoda Y; Iizuka M; Yasuda J; Makino R; Ono T; Kayama T; Yoshimoto T; Sekiya T
Cancer Res; 1995 May; 55(10):2166-8. PubMed ID: 7743518
[TBL] [Abstract][Full Text] [Related]
14. [Genomic imbalance and chromosome disorders in hepatoblastoma].
Gao H; Zhang ZB; Ou YL; Zhang KR; Wang WL
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):915-9. PubMed ID: 17533743
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity at 11q22-q23 in breast cancer.
Carter SL; Negrini M; Baffa R; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM
Cancer Res; 1994 Dec; 54(23):6270-4. PubMed ID: 7954477
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutations of the APC gene in sporadic hepatoblastomas.
Oda H; Imai Y; Nakatsuru Y; Hata J; Ishikawa T
Cancer Res; 1996 Jul; 56(14):3320-3. PubMed ID: 8764128
[TBL] [Abstract][Full Text] [Related]
17. Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma.
Iolascon A; Giordani L; Moretti A; Basso G; Borriello A; Della Ragione F
Hepatology; 1998 Apr; 27(4):989-95. PubMed ID: 9537438
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma.
Shim YH; Park HJ; Choi MS; Kim JS; Kim H; Kim JJ; Jang JJ; Yu E
Mod Pathol; 2003 May; 16(5):430-6. PubMed ID: 12748249
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic abnormalities in hepatoblastoma: report of two new cases and review of the literature suggesting imbalance of chromosomal regions on chromosomes 1, 4, and 12.
Nagata T; Nakamura M; Shichino H; Chin M; Sugito K; Ikeda T; Koshinaga T; Fukuzawa M; Inoue M; Mugishima H
Cancer Genet Cytogenet; 2005 Jan; 156(1):8-13. PubMed ID: 15588850
[TBL] [Abstract][Full Text] [Related]
20. Genomic imprinting and Igf2 influence liver tumorigenesis and loss of heterozygosity in SV40 T antigen transgenic mice.
Haddad R; Held WA
Cancer Res; 1997 Oct; 57(20):4615-23. PubMed ID: 9377577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
